Please Wait
Applying Filters...
menu
    • menu
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    PDS0101

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PDS Biotech Unveils New U.S. Patent For PDS0101 Technology
    PDS Biotech Unveils New U.S. Patent For PDS0101 Technology

    22 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/22/3223777/37149/en/PDS-Biotech-Announces-New-U-S-Patent-Covering-Technology-Underlying-PDS0101.html

    GLOBENEWSWIRE
    22 Jan 2026
    Share Share
    PDS Biotech Aligns With FDA On (PFS) As Primary Endpoint
    PDS Biotech Aligns With FDA On (PFS) As Primary Endpoint

    09 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/09/3216091/37149/en/PDS-Biotech-Announces-FDA-Alignment-on-use-of-Progression-Free-Survival-PFS-as-Primary-Endpoint.html

    GLOBENEWSWIRE
    09 Jan 2026
    Share Share
    PDS Biotech Secures New Patent For PDS0101 In Japan
    PDS Biotech Secures New Patent For PDS0101 In Japan

    09 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/09/3202308/37149/en/PDS-Biotech-Announces-New-Composition-of-Matter-Patent-for-PDS0101-in-Japan.html

    GLOBENEWSWIRE
    09 Dec 2025
    Share Share
    PDS Biotech Announces Type C Meeting with the FDA
    PDS Biotech Announces Type C Meeting with the FDA

    02 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/02/3197934/37149/en/PDS-Biotech-Announces-Scheduling-of-Type-C-Meeting-with-U-S-Food-and-Drug-Administration-FDA.html

    GLOBENEWSWIRE
    02 Dec 2025
    Share Share
    PDS Biotech Reports Q3 2025 Financials And Clinical Programs
    PDS Biotech Reports Q3 2025 Financials And Clinical Programs

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187197/37149/en/PDS-Biotech-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Clinical-Programs-Update.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    PDS Biotech Reveals Strong Immunological Data For PDS0101
    PDS Biotech Reveals Strong Immunological Data For PDS0101

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184578/37149/en/PDS-Biotechnology-Announces-Translational-Data-Showing-Strong-Immunological-and-Clinical-Activity-of-PDS0101-and-PDS01ADC-Presented-at-SITC-2025.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.